Annual FCF
$2.77 B
-$218.82 M-7.32%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual free cash flow is $2.77 billion, with the most recent change of -$218.82 million (-7.32%) on December 31, 2024.
- During the last 3 years, RPRX annual FCF has risen by +$751.45 million (+37.25%).
- RPRX annual FCF is now -7.32% below its all-time high of $2.99 billion, reached on December 31, 2023.
Performance
RPRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$742.52 M
+$38.91 M+5.53%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly free cash flow is $742.52 million, with the most recent change of +$38.91 million (+5.53%) on December 31, 2024.
- Over the past year, RPRX quarterly FCF has dropped by -$30.10 million (-3.90%).
- RPRX quarterly FCF is now -55.46% below its all-time high of $1.67 billion, reached on December 31, 2019.
Performance
RPRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$2.77 B
-$30.10 M-1.08%
December 31, 2024
Summary
- As of February 26, 2025, RPRX TTM free cash flow is $2.77 billion, with the most recent change of -$30.10 million (-1.08%) on December 31, 2024.
- Over the past year, RPRX TTM FCF has dropped by -$218.82 million (-7.32%).
- RPRX TTM FCF is now -11.71% below its all-time high of $3.14 billion, reached on September 30, 2020.
Performance
RPRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RPRX Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.3% | -3.9% | -7.3% |
3 y3 years | +37.3% | -3.9% | -7.3% |
5 y5 years | +66.1% | -3.9% | -7.3% |
RPRX Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -7.3% | +37.3% | -28.2% | +61.3% | -7.3% | +41.9% |
5 y | 5-year | -7.3% | +66.1% | -55.5% | +61.3% | -11.7% | +66.1% |
alltime | all time | -7.3% | +95.2% | -55.5% | +196.5% | -11.7% | -100.0% |
Royalty Pharma Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $2.77 B(-7.3%) | $742.52 M(+5.5%) | $2.77 B(-1.1%) |
Sep 2024 | - | $703.61 M(+6.9%) | $2.80 B(+4.9%) |
Jun 2024 | - | $658.21 M(-1.0%) | $2.67 B(+1.9%) |
Mar 2024 | - | $664.64 M(-14.0%) | $2.62 B(-12.4%) |
Dec 2023 | $2.99 B(+39.4%) | $772.63 M(+34.7%) | $2.99 B(+7.3%) |
Sep 2023 | - | $573.52 M(-5.6%) | $2.79 B(+1.3%) |
Jun 2023 | - | $607.82 M(-41.2%) | $2.75 B(+1.2%) |
Mar 2023 | - | $1.03 B(+81.4%) | $2.72 B(+26.8%) |
Dec 2022 | $2.14 B(+6.3%) | $569.93 M(+5.8%) | $2.14 B(+3.9%) |
Sep 2022 | - | $538.83 M(-6.3%) | $2.06 B(+3.5%) |
Jun 2022 | - | $574.95 M(+24.9%) | $1.99 B(+2.2%) |
Mar 2022 | - | $460.27 M(-6.1%) | $1.95 B(-3.3%) |
Dec 2021 | $2.02 B | $489.96 M(+4.3%) | $2.02 B(-3.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $469.76 M(-11.7%) | $2.09 B(-1.8%) |
Jun 2021 | - | $531.72 M(+1.1%) | $2.13 B(+2.0%) |
Mar 2021 | - | $526.10 M(-7.0%) | $2.09 B(+2.7%) |
Dec 2020 | $2.03 B(+22.0%) | $565.67 M(+11.2%) | $2.03 B(-35.1%) |
Sep 2020 | - | $508.85 M(+4.1%) | $3.14 B(+68.8%) |
Jun 2020 | - | $489.00 M(+3.8%) | $1.86 B(+8.9%) |
Mar 2020 | - | $471.10 M(-71.7%) | $1.71 B(+2.3%) |
Dec 2019 | $1.67 B(+3.0%) | $1.67 B(-316.6%) | $1.67 B(>+9900.0%) |
Sep 2019 | - | -$769.78 M(-328.6%) | $0.00(-100.0%) |
Jun 2019 | - | $336.79 M(-22.2%) | $769.78 M(+77.8%) |
Mar 2019 | - | $432.99 M | $432.99 M |
Dec 2018 | $1.62 B(+14.1%) | - | - |
Dec 2017 | $1.42 B | - | - |
FAQ
- What is Royalty Pharma annual free cash flow?
- What is the all time high annual FCF for Royalty Pharma?
- What is Royalty Pharma annual FCF year-on-year change?
- What is Royalty Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Royalty Pharma?
- What is Royalty Pharma quarterly FCF year-on-year change?
- What is Royalty Pharma TTM free cash flow?
- What is the all time high TTM FCF for Royalty Pharma?
- What is Royalty Pharma TTM FCF year-on-year change?
What is Royalty Pharma annual free cash flow?
The current annual FCF of RPRX is $2.77 B
What is the all time high annual FCF for Royalty Pharma?
Royalty Pharma all-time high annual free cash flow is $2.99 B
What is Royalty Pharma annual FCF year-on-year change?
Over the past year, RPRX annual free cash flow has changed by -$218.82 M (-7.32%)
What is Royalty Pharma quarterly free cash flow?
The current quarterly FCF of RPRX is $742.52 M
What is the all time high quarterly FCF for Royalty Pharma?
Royalty Pharma all-time high quarterly free cash flow is $1.67 B
What is Royalty Pharma quarterly FCF year-on-year change?
Over the past year, RPRX quarterly free cash flow has changed by -$30.10 M (-3.90%)
What is Royalty Pharma TTM free cash flow?
The current TTM FCF of RPRX is $2.77 B
What is the all time high TTM FCF for Royalty Pharma?
Royalty Pharma all-time high TTM free cash flow is $3.14 B
What is Royalty Pharma TTM FCF year-on-year change?
Over the past year, RPRX TTM free cash flow has changed by -$218.82 M (-7.32%)